These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1320540)

  • 1. Clearance of brain natriuretic peptide in patients with chronic heart failure: indirect evidence for a neutral endopeptidase mechanism but against an atrial natriuretic peptide clearance receptor mechanism.
    Lang CC; Motwani JG; Coutie WJ; Struthers AD
    Clin Sci (Lond); 1992 Jun; 82(6):619-23. PubMed ID: 1320540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.
    Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T
    Clin Sci (Lond); 1996 Sep; 91(3):283-91. PubMed ID: 8869410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptides.
    McDowell G; Coutie W; Shaw C; Buchanan KD; Struthers AD; Nicholls DP
    Br J Clin Pharmacol; 1997 Mar; 43(3):329-32. PubMed ID: 9088591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma brain natriuretic peptide and endopeptidase 24.11 inhibition in hypertension.
    Richards AM; Crozier IG; Espiner EA; Yandle TG; Nicholls MG
    Hypertension; 1993 Aug; 22(2):231-6. PubMed ID: 8340158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin-converting enzyme inhibition on plasma brain natriuretic peptide levels in patients with heart failure.
    Lang CC; Motwani JG; Rahman AR; Coutie WJ; Struthers AD
    Clin Sci (Lond); 1992 Aug; 83(2):143-7. PubMed ID: 1327628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-ranging effects of candoxatril on elimination of exogenous atrial natriuretic peptide in chronic heart failure.
    Motwani JG; Lang CC; Allen MJ; Johnson HF; Struthers AD
    Clin Pharmacol Ther; 1993 Dec; 54(6):661-9. PubMed ID: 8275621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of candoxatril and atrial natriuretic factor in healthy men. Effects on hemodynamics, sympathetic activity, heart rate variability, and endothelin.
    Ando S; Rahman MA; Butler GC; Senn BL; Floras JS
    Hypertension; 1995 Dec; 26(6 Pt 2):1160-6. PubMed ID: 7498988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of physiological increments in human alpha-atrial natriuretic peptide and human brain natriuretic peptide in normal male subjects.
    Cheung BM; Dickerson JE; Ashby MJ; Brown MJ; Brown J
    Clin Sci (Lond); 1994 Jun; 86(6):723-30. PubMed ID: 8062508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of candoxatril on plasma brain natriuretic peptide in heart failure.
    Lang CC; Motwani J; Coutie WJ; Struthers AD
    Lancet; 1991 Jul; 338(8761):255. PubMed ID: 1676808
    [No Abstract]   [Full Text] [Related]  

  • 10. Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man.
    Lainchbury JG; Nicholls MG; Espiner EA; Ikram H; Yandle TG; Richards AM
    Clin Sci (Lond); 1998 Nov; 95(5):547-55. PubMed ID: 9791040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive heart failure.
    Kimmelstiel CD; Perrone R; Kilcoyne L; Souhrada J; Udelson J; Smith J; de Bold A; Griffith J; Konstam MA
    Cardiology; 1996; 87(1):46-53. PubMed ID: 8631044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary sodium and inhibition of neutral endopeptidase 24.11 in essential hypertension.
    Singer DR; Markandu ND; Buckley MG; Miller MA; Sagnella GA; MacGregor GA
    Hypertension; 1991 Dec; 18(6):798-804. PubMed ID: 1835959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial and brain natriuretic peptides in cardiovascular diseases.
    Naruse M; Takeyama Y; Tanabe A; Hiroshige J; Naruse K; Yoshimoto T; Tanaka M; Katagiri T; Demura H
    Hypertension; 1994 Jan; 23(1 Suppl):I231-4. PubMed ID: 8282365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension.
    O'Connell JE; Jardine AG; Davidson G; Connell JM
    J Hypertens; 1992 Mar; 10(3):271-7. PubMed ID: 1315825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure.
    Buckley MG; Sethi D; Markandu ND; Sagnella GA; Singer DR; MacGregor GA
    Clin Sci (Lond); 1992 Oct; 83(4):437-44. PubMed ID: 1330406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the short-term effects of candoxatril, an orally active neutral endopeptidase inhibitor, and frusemide in the treatment of patients with chronic heart failure.
    Northridge DB; Newby DE; Rooney E; Norrie J; Dargie HJ
    Am Heart J; 1999 Dec; 138(6 Pt 1):1149-57. PubMed ID: 10577447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
    Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
    Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal and hormonal effects of chronic inhibition of neutral endopeptidase (EC 3.4.24.11) in normal man.
    O'Connell JE; Jardine AG; Davies DL; McQueen J; Connell JM
    Clin Sci (Lond); 1993 Jul; 85(1):19-26. PubMed ID: 8149689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients.
    Kohse KP; Feifel K; Mayer-Wehrstein R
    Clin Nephrol; 1993 Aug; 40(2):83-90. PubMed ID: 8222377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.